HIGHLIGHTS
- who: So Hee Nam from the We transferred human MSCs (BM SS15-P2) from the Catholic Institute of Cell Therapy, Catholic Medical Center, for use in the present studyThe study protocol was approved by the Use Committee of the Clinical Research Institute, Seoul National University Hospital, Seoul, Korea (permit number:, ). These cells were maintained in DMEM-Low Glucose (Biowest, Missouri, USA) containing, % fetal bovine serum (Biowest, Missouri, United States) at , u00b0C with an atmosphere of, % u00adCO2. The medium was changed every, days. To expand the cells, the adhered monolayer was detached using trypsin/EDTA (Gibco, ThermoFisher, Massachusetts . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.